Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/18/2025

Carbidopa-Levodopa Extended Release Side Effects and Management

Metabolic and Nutritional Effects

  • Levodopa therapy is associated with significant weight loss, particularly in women and those on higher doses, primarily due to fat mass reduction 2
  • Hyperhomocysteinemia develops through levodopa methylation by COMT, requiring monitoring of homocysteine, vitamin B12, and folate levels 2, 3
  • Vitamin B6 deficiency may occur with high doses, especially in malnourished patients 3
  • Increasing doses correlate with higher malnutrition risk as assessed by Mini-Nutritional Assessment 2
  • Nausea, vomiting, and anorexia directly compromise nutritional intake 2

Critical Management Considerations

  • Administer carbidopa-levodopa ER at least 30 minutes before meals to avoid protein competition for absorption and maximize therapeutic effect 3
  • Regular nutritional assessment is mandatory, at minimum yearly and whenever clinical status changes 4
  • Vitamin D supplementation should be considered to slow disease progression and reduce fracture risk 4
  • B-vitamin supplementation effectively reduces hyperhomocysteinemia and prevents neuropathy 4

Gastrointestinal Side Effects

  • Dry mouth and taste alterations affect oral comfort and nutrition, according to the Praxis Medical Insights guideline 1

REFERENCES

2

Carbidopa and Levodopa in Parkinson's Disease Treatment [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Jaw Pain and Carbidopa/Levodopa Therapy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025